1. Home
  2. NBTB vs SLNO Comparison

NBTB vs SLNO Comparison

Compare NBTB & SLNO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

NBTB

NBT Bancorp Inc.

HOLD

Current Price

$42.50

Market Cap

2.2B

Sector

Finance

ML Signal

HOLD

Logo Soleno Therapeutics Inc.

SLNO

Soleno Therapeutics Inc.

HOLD

Current Price

$44.78

Market Cap

2.5B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
NBTB
SLNO
Founded
1856
1999
Country
United States
United States
Employees
N/A
N/A
Industry
Major Banks
Biotechnology: Electromedical & Electrotherapeutic Apparatus
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.2B
2.5B
IPO Year
N/A
2014

Fundamental Metrics

Financial Performance
Metric
NBTB
SLNO
Price
$42.50
$44.78
Analyst Decision
Buy
Strong Buy
Analyst Count
2
10
Target Price
$51.00
$110.90
AVG Volume (30 Days)
223.0K
1.3M
Earning Date
01-26-2026
02-26-2026
Dividend Yield
3.45%
N/A
EPS Growth
5.89
N/A
EPS
3.02
N/A
Revenue
$629,728,000.00
$98,675,000.00
Revenue This Year
$27.08
N/A
Revenue Next Year
$9.17
$155.86
P/E Ratio
$14.19
N/A
Revenue Growth
16.88
N/A
52 Week Low
$37.31
$41.50
52 Week High
$49.18
$90.32

Technical Indicators

Market Signals
Indicator
NBTB
SLNO
Relative Strength Index (RSI) 51.25 36.74
Support Level $41.02 $45.07
Resistance Level $43.04 $47.98
Average True Range (ATR) 0.87 1.88
MACD -0.14 -0.18
Stochastic Oscillator 43.01 1.59

Price Performance

Historical Comparison
NBTB
SLNO

About NBTB NBT Bancorp Inc.

NBT Bancorp Inc is a financial holding company that operates through its subsidiaries. The company's principal sources of revenue include management fees and dividends it receives through its subsidiaries. Its business, predominantly conducted through NBT Bank, consists of providing commercial banking, retail banking, and wealth management services to customers in its market area, which includes upstate New York, northeastern Pennsylvania, southern New Hampshire, western Massachusetts, Vermont, southern Maine, and central and northwestern Connecticut. The company's reportable segments are Banking and Retirement Plan Administration. A majority of its revenue is generated from the Banking segment.

About SLNO Soleno Therapeutics Inc.

Soleno Therapeutics Inc is a biopharmaceutical company developing novel therapeutics for the treatment of rare diseases. Its product candidate DCCR (Diazoxide Choline) Extended-Release tablets, is a proprietary extended-release formulation of a crystalline salt of diazoxide. DCCR has demonstrated the ability to activate the KATP channel in the brain, pancreas, and fat tissue.

Share on Social Networks: